↓ Skip to main content

Advanced stage melanoma therapies: Detailing the present and exploring the future

Overview of attention for article published in Critical Reviews in Oncology/Hematology, November 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users
facebook
1 Facebook page

Readers on

mendeley
78 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Advanced stage melanoma therapies: Detailing the present and exploring the future
Published in
Critical Reviews in Oncology/Hematology, November 2018
DOI 10.1016/j.critrevonc.2018.11.002
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 78 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 78 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Bachelor 11 14%
Student > Master 11 14%
Researcher 10 13%
Student > Ph. D. Student 5 6%
Other 3 4%
Other 9 12%
Unknown 29 37%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 16 21%
Biochemistry, Genetics and Molecular Biology 14 18%
Pharmacology, Toxicology and Pharmaceutical Science 7 9%
Agricultural and Biological Sciences 3 4%
Immunology and Microbiology 2 3%
Other 4 5%
Unknown 32 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 March 2019.
All research outputs
#15,745,807
of 25,385,509 outputs
Outputs from Critical Reviews in Oncology/Hematology
#1,271
of 1,947 outputs
Outputs of similar age
#197,244
of 354,396 outputs
Outputs of similar age from Critical Reviews in Oncology/Hematology
#12
of 23 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,947 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one is in the 33rd percentile – i.e., 33% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 354,396 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.